Zhui Chen - 1Abbisko Therapeutics | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 15 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 2039: Cellular characterization of small molecule PD-L1 inhibitors reveal their novel mechanisms of action

Weiling Pan,Yongxian Zhang, Fangfei Qi,Wenqun Xin, Zhigang Feng,Zhui Chen,Haiyan Ying

Cancer Researchno. 6_Supplement (2024): 2039-2039

引用0浏览0引用

A potent and selective small molecule inhibitor of CSF-1R ABSK021 demonstrates strong efficacy in preclinical models of osteosarcoma

Nannan Zhang, Cheng Dai, Jiacheng Zhang,Shuqun Yang,Jie Wang,Jie Zhang, Manqi Liu,Zhui Chen

CANCER RESEARCHno. 8 (2023): LB329-LB329

引用0浏览0引用

Abstract LB328: Discovery & characterization of a next-generation FGFR4 inhibitor overcoming resistant mutations

Haiyan Ying, Nannan Zhang, Haibing Deng, Fei Yang,Wenqun Xin, Bin Shen, Hong‐Ren Yu,Zhui Chen,Yao‐Chang Xu

Cancer Researchno. 8_Supplement (2023): LB328-LB328

引用0浏览0引用

TCGA RNA-Seq and Tumor-Infiltrating Lymphocyte Imaging Data Reveal Cold Tumor Signatures of Invasive Ductal Carcinomas and Estrogen Receptor-Positive Human Breast Tumors

Mayassa J Bou-Dargham,Linlin Sha,Drishty B Sarker, Martina Z Krakora-Compagno,Zhui Chen,Jinfeng Zhang,Qing-Xiang Amy Sang

International journal of molecular sciencesno. 11 (2023): 9355-9355

引用0浏览0WOS引用

Discovery and characterization of ABSK112, a next-generation and potential best-inclass EGFR Exon20 mutant inhibitor with superior selectivity and brain penetration ability

Mei Ning,Shuqun Yang, Juan Peng, Shuangyun Hu, Weijia Lu, Cheng Dai, Baowei Zhao, Mingming Zhang,Hongping Yu,Zhui Chen,Yao-chang Xu

CANCER RESEARCHno. 8 (2023): LB327-LB327

引用0浏览0引用

Abstract LB317: Discovery and characterization of a next-generation FGFR inhibitor overcoming FGFR resistant mutations

Haiyan Ying,Wenqun Xin, Haibing Deng, Yuan Zhao, Hong‐Ren Yu,Zhui Chen,Yao‐Chang Xu

Cancer Researchno. 8_Supplement (2023): LB317-LB317

引用0浏览0引用

Discovery and characterization of a next-generation FGFR inhibitor overcoming FGFR resistant mutations

Haiyan Ying,Wenqun Xin, Haibing Deng,Yuan Zhao,Hongping Yu,Zhui Chen,Yao-chang Xu

CANCER RESEARCHno. 8 (2023)

引用0浏览0引用

Discovery and characterization of ABSK111, a selective, CNS-penetrable, and broad-spectrum EGFR inhibitor targeting exon20 insertion, atypical and extracellular mutations

Cheng Dai, Juan Peng, Fei Yang, Haibing Deng, Yuan Zhao,Hongping Yu,Yaochang Xu,Zhui Chen,Shuqun Yang

CANCER RESEARCHno. 12 (2022)

引用0浏览0引用

1441 A potent and selective small molecule antagonist of CD73 ABSK051 reverses immunosuppression through reduction of adenosine production

Haibing Deng,Wenqun Xin, Weiling Pan,Zhixuan Zhu,Mei Ning,Hongping Yu,Zhui Chen,Haiyan Ying

Regular and Young Investigator Award Abstracts (2022): A1500-A1500

引用0浏览0引用

Abstract LB525: Discovery and characterization of ABSK111, a selective, CNS-penetrable, and broad-spectrum EGFR inhibitor targeting exon20 insertion, atypical and extracellular mutations

Cheng Dai, Juan Peng, Fei Yang, Haibing Deng, Yuan Zhao,Hongping Yu,Yaochang Xu,Zhui Chen,Shuqun Yang

Cancer Researchno. 12_Supplement (2022): LB525-LB525

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn